Global T Cell Transfer Therapy Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T Cell Transfer Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global T Cell Transfer Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Child
1.3.3 Adult
1.3.4 The Elderly
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global T Cell Transfer Therapy Market Perspective (2017-2028)
2.2 T Cell Transfer Therapy Growth Trends by Region
2.2.1 T Cell Transfer Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 T Cell Transfer Therapy Historic Market Size by Region (2017-2022)
2.2.3 T Cell Transfer Therapy Forecasted Market Size by Region (2023-2028)
2.3 T Cell Transfer Therapy Market Dynamics
2.3.1 T Cell Transfer Therapy Industry Trends
2.3.2 T Cell Transfer Therapy Market Drivers
2.3.3 T Cell Transfer Therapy Market Challenges
2.3.4 T Cell Transfer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top T Cell Transfer Therapy Players by Revenue
3.1.1 Global Top T Cell Transfer Therapy Players by Revenue (2017-2022)
3.1.2 Global T Cell Transfer Therapy Revenue Market Share by Players (2017-2022)
3.2 Global T Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by T Cell Transfer Therapy Revenue
3.4 Global T Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global T Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T Cell Transfer Therapy Revenue in 2021
3.5 T Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players T Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into T Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 T Cell Transfer Therapy Breakdown Data by Type
4.1 Global T Cell Transfer Therapy Historic Market Size by Type (2017-2022)
4.2 Global T Cell Transfer Therapy Forecasted Market Size by Type (2023-2028)
5 T Cell Transfer Therapy Breakdown Data by Application
5.1 Global T Cell Transfer Therapy Historic Market Size by Application (2017-2022)
5.2 Global T Cell Transfer Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America T Cell Transfer Therapy Market Size (2017-2028)
6.2 North America T Cell Transfer Therapy Market Size by Country (2017-2022)
6.3 North America T Cell Transfer Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe T Cell Transfer Therapy Market Size (2017-2028)
7.2 Europe T Cell Transfer Therapy Market Size by Country (2017-2022)
7.3 Europe T Cell Transfer Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific T Cell Transfer Therapy Market Size (2017-2028)
8.2 Asia-Pacific T Cell Transfer Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific T Cell Transfer Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America T Cell Transfer Therapy Market Size (2017-2028)
9.2 Latin America T Cell Transfer Therapy Market Size by Country (2017-2022)
9.3 Latin America T Cell Transfer Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa T Cell Transfer Therapy Market Size (2017-2028)
10.2 Middle East & Africa T Cell Transfer Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa T Cell Transfer Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche T Cell Transfer Therapy Introduction
11.1.4 Roche Revenue in T Cell Transfer Therapy Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck T Cell Transfer Therapy Introduction
11.2.4 Merck Revenue in T Cell Transfer Therapy Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis T Cell Transfer Therapy Introduction
11.3.4 Novartis Revenue in T Cell Transfer Therapy Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson T Cell Transfer Therapy Introduction
11.4.4 Johnson & Johnson Revenue in T Cell Transfer Therapy Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Detail
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline T Cell Transfer Therapy Introduction
11.5.4 Glaxosmithkline Revenue in T Cell Transfer Therapy Business (2017-2022)
11.5.5 Glaxosmithkline Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen T Cell Transfer Therapy Introduction
11.6.4 Amgen Revenue in T Cell Transfer Therapy Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie T Cell Transfer Therapy Introduction
11.7.4 Abbvie Revenue in T Cell Transfer Therapy Business (2017-2022)
11.7.5 Abbvie Recent Development
11.8 Astrazeneca
11.8.1 Astrazeneca Company Detail
11.8.2 Astrazeneca Business Overview
11.8.3 Astrazeneca T Cell Transfer Therapy Introduction
11.8.4 Astrazeneca Revenue in T Cell Transfer Therapy Business (2017-2022)
11.8.5 Astrazeneca Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb T Cell Transfer Therapy Introduction
11.9.4 Bristol-Myers Squibb Revenue in T Cell Transfer Therapy Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 ELI Lilly
11.10.1 ELI Lilly Company Detail
11.10.2 ELI Lilly Business Overview
11.10.3 ELI Lilly T Cell Transfer Therapy Introduction
11.10.4 ELI Lilly Revenue in T Cell Transfer Therapy Business (2017-2022)
11.10.5 ELI Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global T Cell Transfer Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global T Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global T Cell Transfer Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global T Cell Transfer Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global T Cell Transfer Therapy Market Share by Region (2017-2022)
Table 8. Global T Cell Transfer Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global T Cell Transfer Therapy Market Share by Region (2023-2028)
Table 10. T Cell Transfer Therapy Market Trends
Table 11. T Cell Transfer Therapy Market Drivers
Table 12. T Cell Transfer Therapy Market Challenges
Table 13. T Cell Transfer Therapy Market Restraints
Table 14. Global T Cell Transfer Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global T Cell Transfer Therapy Market Share by Players (2017-2022)
Table 16. Global Top T Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T Cell Transfer Therapy as of 2021)
Table 17. Ranking of Global Top T Cell Transfer Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by T Cell Transfer Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players T Cell Transfer Therapy Product Solution and Service
Table 21. Date of Enter into T Cell Transfer Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global T Cell Transfer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global T Cell Transfer Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global T Cell Transfer Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global T Cell Transfer Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global T Cell Transfer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global T Cell Transfer Therapy Revenue Market Share by Application (2017-2022)
Table 29. Global T Cell Transfer Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global T Cell Transfer Therapy Revenue Market Share by Application (2023-2028)
Table 31. North America T Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America T Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe T Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe T Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific T Cell Transfer Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific T Cell Transfer Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America T Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America T Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa T Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa T Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Roche Company Detail
Table 42. Roche Business Overview
Table 43. Roche T Cell Transfer Therapy Product
Table 44. Roche Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 45. Roche Recent Development
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck T Cell Transfer Therapy Product
Table 49. Merck Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis T Cell Transfer Therapy Product
Table 54. Novartis Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson T Cell Transfer Therapy Product
Table 59. Johnson & Johnson Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Glaxosmithkline Company Detail
Table 62. Glaxosmithkline Business Overview
Table 63. Glaxosmithkline T Cell Transfer Therapy Product
Table 64. Glaxosmithkline Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 65. Glaxosmithkline Recent Development
Table 66. Amgen Company Detail
Table 67. Amgen Business Overview
Table 68. Amgen T Cell Transfer Therapy Product
Table 69. Amgen Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Abbvie Company Detail
Table 72. Abbvie Business Overview
Table 73. Abbvie T Cell Transfer Therapy Product
Table 74. Abbvie Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 75. Abbvie Recent Development
Table 76. Astrazeneca Company Detail
Table 77. Astrazeneca Business Overview
Table 78. Astrazeneca T Cell Transfer Therapy Product
Table 79. Astrazeneca Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 80. Astrazeneca Recent Development
Table 81. Bristol-Myers Squibb Company Detail
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb T Cell Transfer Therapy Product
Table 84. Bristol-Myers Squibb Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. ELI Lilly Company Detail
Table 87. ELI Lilly Business Overview
Table 88. ELI Lilly T Cell Transfer Therapy Product
Table 89. ELI Lilly Revenue in T Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 90. ELI Lilly Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of FiguresFigure 1. Global T Cell Transfer Therapy Market Share by Type: 2021 VS 2028
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global T Cell Transfer Therapy Market Share by Application in 2021 & 2028
Figure 5. Child Case Studies
Figure 6. Adult Case Studies
Figure 7. The Elderly Case Studies
Figure 8. T Cell Transfer Therapy Report Years Considered
Figure 9. Global T Cell Transfer Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global T Cell Transfer Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global T Cell Transfer Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global T Cell Transfer Therapy Market Share by Players in 2021
Figure 13. Global Top T Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T Cell Transfer Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by T Cell Transfer Therapy Revenue in 2021
Figure 15. North America T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America T Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 17. United States T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe T Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 21. Germany T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific T Cell Transfer Therapy Market Share by Region (2017-2028)
Figure 29. China T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America T Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 37. Mexico T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa T Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 41. Turkey T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia T Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Roche Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 44. Merck Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 45. Novartis Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 46. Johnson & Johnson Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 47. Glaxosmithkline Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 48. Amgen Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 49. Abbvie Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 50. Astrazeneca Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 52. ELI Lilly Revenue Growth Rate in T Cell Transfer Therapy Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed